Stock analysts at Bank of America began coverage on shares of McKesson (NYSE:MCK) in a research note issued on Tuesday, The Fly reports. The firm set a “buy” rating on the stock.
Several other research analysts have also recently commented on the company. Zacks Investment Research cut McKesson from a “buy” rating to a “hold” rating in a research note on Wednesday, February 21st. ValuEngine cut McKesson from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Credit Suisse Group reiterated a “sell” rating and issued a $130.00 price target on shares of McKesson in a research note on Friday, February 2nd. Mizuho cut their price target on McKesson from $186.00 to $179.00 and set a “neutral” rating on the stock in a research note on Friday, February 2nd. Finally, Jefferies Group upgraded McKesson from a “hold” rating to a “buy” rating and set a $205.00 price target on the stock in a research note on Wednesday, January 24th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have assigned a buy rating to the company. McKesson has an average rating of “Hold” and a consensus target price of $177.79.
Shares of McKesson (MCK) opened at $154.52 on Tuesday. McKesson has a 1 year low of $133.82 and a 1 year high of $178.86. The company has a quick ratio of 0.61, a current ratio of 1.07 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $31,497.69, a PE ratio of 6.85, a PEG ratio of 1.39 and a beta of 1.23.
In other McKesson news, Chairman John H. Hammergren sold 65,000 shares of the company’s stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total transaction of $10,400,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.20% of the company’s stock.
Several institutional investors have recently made changes to their positions in the company. Nationwide Fund Advisors grew its holdings in McKesson by 4.8% in the 3rd quarter. Nationwide Fund Advisors now owns 272,349 shares of the company’s stock worth $41,836,000 after buying an additional 12,464 shares in the last quarter. Financial Sense Advisors Inc. grew its holdings in McKesson by 20.7% in the 3rd quarter. Financial Sense Advisors Inc. now owns 21,615 shares of the company’s stock worth $3,320,000 after buying an additional 3,700 shares in the last quarter. Calamos Advisors LLC grew its holdings in McKesson by 3.8% in the 3rd quarter. Calamos Advisors LLC now owns 24,491 shares of the company’s stock worth $3,762,000 after buying an additional 898 shares in the last quarter. Pictet Asset Management Ltd. grew its holdings in McKesson by 3.7% in the 3rd quarter. Pictet Asset Management Ltd. now owns 113,808 shares of the company’s stock worth $17,482,000 after buying an additional 4,100 shares in the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in McKesson in the 3rd quarter worth approximately $3,532,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “McKesson (MCK) Coverage Initiated by Analysts at Bank of America” was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3225342/mckesson-mck-coverage-initiated-by-analysts-at-bank-of-america.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.